#Health / Well-being #Diagnostics
- Animal health
- Molecular biology
- Rapid test
As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.Discover >
Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.Discover >
Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.Discover >
Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.Discover >
#Health / Well-being #Diagnostics
Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.
Enalees was created in December of 2015.
The company joined Genopole and became Genopole-accredited in February 2016. After two years of research, Enalees commercialized its first tests, Epona, for veterinarians working with horses, and a year later it brought the Astéria line to market for veterinarians working with dogs. Enalees also developed a SARS-CoV-2 diagnostic test during the COVID-19 pandemic to detect the causative virus in humans, cats, and the environment.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
The purpose of Enalees’ rapid tests is to diagnose a disease via a portable reader within 40 minutes with no need to send samples to a specialized laboratory.
Also, in 2021, Enalees will begin offering a freeze drying service to numerous businesses thanks to its new lyophilization platform located at Genopole.
CUSTOMER REFERENCES / COLLABORATIONS / HIGHLIGHTS
15 staff members
Simple and rapid detection of pathogens in less than 40 minutes on a portable and affordable device. Energetic and innovative team.
In same field
CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.Discover
Research & development for an in vitro diagnostic tool for endometriosisDiscover
SafeInsight seeks to provide a response to the growing concerns of consumers for the composition of the products they buy and accompanies manufacturers aiming to attentively circumscribe the problem of endocrine disruptors.Discover
Ciclix is a tech driven company specialized in process digitization for hospitals and focused on creating natural and efficient solutions for a variety of user profiles in the hospital environment.Discover
Echoliv is a MedTech startup that develops solutions based on artificial intelligence and applied to hepatic ultrasound. Our goal is to develop software to assist radiologists and hepatologists.Discover
Floating Genes develops diagnostic tools for use in liquid biopsies via the highly sensitive NGS detection of circulating tumor DNA.Discover
– Characterization of antigen / antibody interactions (epitope / paratope) – Optimization of therapeutic antibodiesDiscover
Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.Discover
Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell DiseaseDiscover
IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.Discover
AgenT is developing an unprecedented blood test to identify patients with Alzheimer's disease much earlier in disease course than current detection methods are able to do. The company also does drug repositioning research to identify compounds potentially active in the silent phase of Alzheimer's disease.Discover